Is CHWY a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Autoship makes the revenue sticky, with gross margin (q2 fy2026) at 30.4%. The bear case rests on chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Analysts covering it are spread from $21.00 to $36.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $21.00, +0.1% from the $20.97 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Autoship makes the revenue sticky. Autoship, Chewy's auto-replenishment subscription, drove 84.6% of net sales in the second quarter of fiscal 2026, which is rare predictability for a retailer. The most optimistic analyst target on CHWY is $36.00, +71.7% from the $20.97 price. That figure is only reachable if this thesis works close to its best case.

Chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot. Growth has slowed as the US pet market matures, with net sales up only about 6% in fiscal 2025 and active-customer growth modest after a long stretch of flat-to-declining counts following the pandemic pet boom. Competition is intense and well-capitalized: Amazon, Walmart, big-box pet chains like PetSmart and Petco, and local veterinarians all compete for the same wallet. The vet-clinic expansion carries execution and integration risk and weighs on near-term profit, while share-based compensation and ongoing BC Partners stock sales create dilution and overhang. Chewy also now carries more debt (about $1.16 billion after a $600 million term loan used around the Modern Animal deal) against about $612 million of cash. Finally, the stock has historically traded at a premium that bakes in continued margin gains; even after falling about 37% in 2026 it sits near 33 times trailing earnings, so disappointing customer growth or margin progress can still pressure the shares. The most pessimistic published target is $21.00, +0.1% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

The largest US online pet retailer, built around its Autoship subscription and expanding into higher-margin pharmacy, advertising, and vet-care businesses.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Autoship makes the revenue sticky) stalling in the reported numbers rather than in the narrative, the risk above (chewy operates in a structurally low-margin retail business, so even with mix improvements its net margins sit in the low single digits and small cost or pricing shifts matter a lot) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Chewy is the largest online retailer of pet products in the US. It sells pet food, treats, supplies, and prescription medications, mostly through its Autoship auto-replenishment subscription, and is expanding into pet healthcare with Chewy Pharmacy, a retail-media advertising network, and a growing chain of Chewy Vet Care clinics.

No. Chewy does not pay a dividend. It returns capital to shareholders through share repurchases instead, deploying roughly $200 million on buybacks in each of the first two quarters of fiscal 2026, partly to offset dilution from share-based compensation and stock sold by its longtime backer BC Partners.

Autoship is Chewy's subscription that automatically reships food and supplies on a set schedule. It accounted for 84.6% of net sales in the second quarter of fiscal 2026, which gives Chewy unusually predictable, recurring revenue for a retailer because pet food and medications are repeat, non-discretionary purchases.